Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
542
datasets available to search
ShareScore release 0.9.0
Dataset results
542 results for “HIV prevention”
Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampal
ClinicalTrials.gov study NCT04030520. IPD Sharing: NO. Countries: 1. Publications: 0.
Prevention of Milk-Borne Transmission of HIV-1C in Botswana
ClinicalTrials.gov study NCT00197587. IPD Sharing: Not stated. Countries: 0. Publications: 7.
HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings
ClinicalTrials.gov study NCT01256463. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
ClinicalTrials.gov study NCT00000908. IPD Sharing: Not stated. Countries: 2. Publications: 1.
HIV Prevention Counseling for Men Who Have Sex With Men
ClinicalTrials.gov study NCT00000931. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
ClinicalTrials.gov study NCT00000590. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
ClinicalTrials.gov study NCT00001028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South
ClinicalTrials.gov study NCT03487796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women
ClinicalTrials.gov study NCT01315353. IPD Sharing: Not stated. Countries: 7. Publications: 0.
HIV Prevention Preparedness Study
ClinicalTrials.gov study NCT00048282. IPD Sharing: Not stated. Countries: 3. Publications: 3.
A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
ClinicalTrials.gov study NCT00183456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effectiveness of a Mobile-based HIV Prevention Intervention Involving Incentive Policy for Doctors in Liangshan, China
ClinicalTrials.gov study NCT05015062. IPD Sharing: Not stated. Countries: 0. Publications: 1.
An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents
ClinicalTrials.gov study NCT03713034. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia
Open the record for dataset details and reuse information.
Pharmacological Inhibition of PPARγ Reverses HIV Latency but Prevents Viral Production/Infectivity while Boosting Th17 Functions
GEO Series GSE128121. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Vaccine-induced tissue resident memory T cells and antibodies synergize to prevent mucosal HIV infection [CITE-seq]
GEO Series GSE138156. Macaca mulatta. 2 samples. Type: Expression profiling by high throughput sequencing.
Data from: Understanding willingness to use oral pre-exposure prophylaxis for HIV prevention among men who have sex with men in China
Background: Oral pre-exposure prophylaxis (PrEP) is recommended as an additional prevention choice for men who have sex with men (MSM) at substantial risk of HIV. The aim of this study was to evaluate the extent, and reasons, for MSM's willingness to use oral PrEP in Wuhan and Shanghai, China. Methods: Between May and December 2015, a cross-sectional survey was conducted among 487 MSM recruited through snowball sampling in physical locations frequented by MSM and through social media applications. Exploratory factor analysis was used to group reasons for being willing or not willing to use PrEP. Chi-square tests were used to explore bivariate associations between groupings of reasons for being willing or unwilling to use PrEP, and key sociodemographic and sexual-behavioral characteristics of MSM. Results: Overall, 71.3% of respondents were willing to use PrEP. The most commonly reported reasons for being willing to use PrEP were preventing HIV infection (91.6%), taking responsibility for own sexual health (72.6%) and protecting family members from harm (59.4%). The main reasons for being unwilling to use PrEP were being worried about side effects (72.9%), the necessity of taking PrEP for long periods of time (54.3%) and cost (40.4%). Individual characteristics that influenced the type of reasons given for being willing or unwilling to use PrEP included being married to a woman, having a regular sex partner, rates of condom use with regular and casual sex partners, and the number of casual sex partners. Conclusion: The introduction of PrEP in China could benefit from promotion campaigns that emphasize its role in preventing HIV infection, in taking responsibility for own sexual health, and in protecting family members from potential harm. To reduce uptake barriers, it will be essential to provide accurate information to potential PrEP users about the mild and short-term nature of side effects, and the possibility of taking PrEP only during particular periods of life when the risk of HIV exposure might be highest.
Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
ClinicalTrials.gov study NCT00601237. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MHealth HIV Prevention for Transgender Women
ClinicalTrials.gov study NCT05271097. IPD Sharing: NO. Countries: 1. Publications: 0.
A Social Network Approach for Improving Medication Assisted Treatment and HIV Prevention and Medical Care Among People Who Inject Drugs in Ukraine
ClinicalTrials.gov study NCT05824702. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.